Skip to main content
. 2001 Jun;69(6):3762–3771. doi: 10.1128/IAI.69.6.3762-3771.2001

TABLE 2.

Summary of anti-NspA MAb surface reactivity for genetically diverse N. meningitidis serogroup B strains

Strain Surface reactivity (flow) of anti-NspA MAbs and/or complement-mediated BCAa
AL4
AL5
AL11
AL12
Flowb BCA Flow BCA Flow BCA Flow BCA
8047 + >60 45 15 ++ 8
CU385 ++ >120 + >120 + >120 ++ >120
BZ198 ++ 26 ++ 5 ++ 4 ++ 5
S3446 ++ >60 ++ >60 ++ 60 ++ 32
1000 + >120 >120 >120 ++ 110
BZ232 variable >120 >120 >120 variable >120
NG3/88 ++ >120 + >120 ++ >120 ++ >120
NGP165 >120 >120 >120 >120
MC58 variable >120 variable >120 variable >120 variable >120
M986 >120 >120 >120 >120
BZ198ΔNspA >60 >60 >60 >60
a

BCA, bactericidal activity (concentration of MAb that when incubated for 60 min with bacterial cells and 20% human complement yielded a 50% decrease in CFU per ml compared to that at time zero). 

b

Surface binding was measured by flow cytometry. With one exception, all strains were tested at MAb concentrations of 10 and 60 μg/ml. The exception, strain BZ198, was tested at 6 and 60 μg/ml. Results were scored as follows: −, less than 50% of total fluorescent events have intensity above background when tested at 60 μg of MAb per ml; +, ≥50% of total fluorescent events have intensity above background at 60 μg/ml; ++, ≥50% of total fluorescent events have intensity above background at 6 or 10 μg/ml; variable, subcultures ranged from − to ++ (see text).